论文部分内容阅读
双时相门冬胰岛素30(BIAsp30)较预混人胰岛素能够更好地模拟生理性胰岛素的分泌,起效快、峰值高,餐前注射能有效控制空腹和餐后血糖水平。BIAsp30应用于起始胰岛素治疗的2型糖尿病患者能获得良好的血糖控制,同时全天血糖水平更加平稳,低血糖事件的发生风险小。每日3次使用BIAsp30可以作为简单的强化治疗手段获得显著疗效。BIAsp30由于兼顾了有效性、安全性及灵活性,利用一种制剂、一种注射装置给患者的用药和医生进行临床治疗提供了更多便利。
Compared with pre-mixed insulin, bi-phase aspart insulin 30 (BIAsp30) can better simulate the secretion of physiological insulin with fast onset and high peak, and pre-meal injection can effectively control fasting and postprandial blood glucose levels. Patients with type 2 diabetes who are using BIAsp30 for initial insulin therapy receive good glycemic control, with a smoother blood glucose level throughout the day and a lower risk of hypoglycaemic events. Using BIAsp30 3 times a day can achieve significant results as a simple intensive treatment. The BIAsp30 offers the convenience of a patient’s medication and physician’s clinical treatment with a single formulation that takes into account the effectiveness, safety and flexibility of an injection device.